The Basics
What is Loperamide?
Used for the control and symptomatic relief of acute nonspecific diarrhea and of chronic diarrhea that is associated with IBD.
Brand names for Loperamide
Imodium
How Loperamide is classified
Antidiarrheals, Gastrointestinal Agents
Loperamide During Pregnancy
Loperamide pregnancy category
Category CNote that the FDA has deprecated the use of pregnancy categories, so for some medications, this information isn’t available. We still think it’s useful to list historical info, however, given what a common proxy this has been in the past.
What we know about taking Loperamide while pregnant
Teratology studies have been performed in rats using oral doses of 2.5, 10, and 40 mg/kg/day, and in rabbits using oral doses of 5, 20, and 40 mg/kg/day. These studies have revealed no evidence of impaired fertility or harm to the fetus at doses up to 10 mg/kg/day in rats (5 times the human dose based on body surface area comparison) and 40 mg/kg/day in rabbits (43 times the human dose based on body surface area comparison). Treatment of rats with 40 mg/kg/day p.o. (21 times the human dose based on a body surface area comparison) produced marked impairment of fertility. The studies produced no evidence of teratogenic activity. There are no adequate and well-controlled studies in pregnant women. Loperamide should be used during pregnancy only if the potential benefit justifies the potential risk to the fetus.
Taking Loperamide While Breastfeeding
What are recommendations for lactation if you're taking Loperamide?
Use of loperamide during breastfeeding is unlikely to affect the infant.
Maternal / infant drug levels
Use of loperamide during breastfeeding is unlikely to affect the infant.
Possible effects of Loperamide on milk supply
Relevant published information was not found as of the revision date.
Possible alternatives to Loperamide
List of References
Lactation sources: Drugs and Lactation Database (LactMed) [Internet]. Bethesda (MD): National Library of Medicine (US); 2006-. Available from: https://www.ncbi.nlm.nih.gov/books/NBK501922/1. Nikodem VC, Hofmeyr GJ. Secretion of the antidiarrhoeal agent loperamide oxide in breast milk. Eur J Clin Pharmacol. 1992;42:695-6. PMID: 1623917
Disclaimer: This material is provided for educational purposes only and is not intended for medical advice, diagnosis, or treatment. Consult your healthcare provider with any questions.